Orilissa | Elagolix Tablet while Breastfeeding
Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Orilissa | Elagolix Tablet while breast-feeding.

What is Orilissa | Elagolix Tablet used for?


ORILISSA is indicated for the management of moderate to severe pain associated with endometriosis. ORILISSA is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis. (1)

I am breastfeeding mother and I am using Orilissa | Elagolix Tablet. Can it have any bad effect on my kid? Shall I search for better alternative?

Orilissa | Elagolix Tablet contains Elagolix sodium as active ingredients, . We do not have safety rating of Elagolix sodium but we do have analysis of Elagolix sodium, which is used in manufacturing of Orilissa | Elagolix Tablet. You can get a good idea about Orilissa | Elagolix Tablet usage while breastfeeding by going through our detailed analysis as below.

Orilissa | Elagolix Tablet Breastfeeding Analsys


Elagolix sodium while Breastfeeding

CAS Number: 834153-87-6

No information is available on the use of elagolix during breastfeeding. Elagolix is 80% protein bound, has a half-life of 4 to 6 hours, and it is a peptide that is likely digested in the infant's gastrointestinal tract, so it is unlikely to reach clinically important levels in infant serum. If elagolix is required by the mother, it is not a reason to discontinue breastfeeding. However, because no information is available on the use of elagolix during breastfeeding caution should be used, especially while nursing a newborn or preterm infant.


Orilissa | Elagolix Tablet and breastfeeding

I am nursing mother and I have already used Orilissa | Elagolix Tablet, what should I do?

We are not completely sure about safety of Orilissa | Elagolix Tablet in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Orilissa | Elagolix Tablet. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


I am nursing mother and my doctor has suggested me to use Orilissa | Elagolix Tablet, is it safe?

If your doctor considers Orilissa | Elagolix Tablet safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Orilissa | Elagolix Tablet, will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Orilissa | Elagolix Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week